Literature DB >> 26087006

What You See Is What You Get: Lead Location Within Deep Brain Structures Is Accurately Depicted by Stereotactic Magnetic Resonance Imaging.

Jonathan A Hyam1, Harith Akram, Thomas Foltynie, Patricia Limousin, Marwan Hariz, Ludvic Zrinzo.   

Abstract

BACKGROUND: Magnetic resonance imaging (MRI)-verified deep brain stimulation relies on the correct interpretation of stereotactic imaging documenting lead location in relation to visible anatomic target. However, it has been suggested that local signal distortion from the lead itself renders its depiction on MRI unreliable.
OBJECTIVE: To compare lead location on stereotactic MRI with subsequent location of its brain track after removal.
METHODS: Patients underwent deep brain stimulation with the use of MRI-guided and MRI-verified Leksell frame approach. Infection or suboptimal efficacy required lead removal and subsequent reimplantation by using the same technique. Postimplantation stereotactic MR images were analyzed. Lateral (x) and anteroposterior (y) distances from midcommissural point to center of the lead hypointensity were recorded at the anterior commissure-posterior commissure plane (pallidal electrode) or z = -4 (subthalamic electrode). Stereotactic MRI before the second procedure, x and y distances from the center of the visible lead track hypointensity to midcommissural point were independently recorded. Vectorial distance from center of the lead hypointensity to the center of its track was calculated.
RESULTS: Sixteen electrode tracks were studied in 10 patients. Mean differences between lead artifact location and lead track location were: x coordinate 0.4 mm ± 0.2; y coordinate 0.6 mm ± 0.3. Mean vectorial distance was 0.7 mm ± 0.2.
CONCLUSION: Stereotactic distance between lead location and subsequent brain track location on MRI was small. The mean discrepancy was approximately half the deep brain stimulation lead width. This suggests that lead hypointensity seen on postimplantation MRI is indeed an accurate representation of its real location within deep brain structures.

Entities:  

Mesh:

Year:  2015        PMID: 26087006     DOI: 10.1227/NEU.0000000000000848

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  6 in total

1.  Optimizing the deep brain stimulation care pathway in patients with Parkinson's disease.

Authors:  N J Thomas; P Mertens; T Danaila; G Polo; H Klinger; E Broussolle; S Thobois
Journal:  J Neurol       Date:  2017-06-19       Impact factor: 4.849

2.  Direct visualization of deep brain stimulation targets in patients with Parkinson's disease via 3-T quantitative susceptibility mapping.

Authors:  Kaijia Yu; Zhiwei Ren; Jianyu Li; Song Guo; Yongsheng Hu; Yongjie Li
Journal:  Acta Neurochir (Wien)       Date:  2021-02-11       Impact factor: 2.216

Review 3.  Targeting of the Subthalamic Nucleus in Patients with Parkinson's Disease Undergoing Deep Brain Stimulation Surgery.

Authors:  Pepijn van den Munckhof; Maarten Bot; P Richard Schuurman
Journal:  Neurol Ther       Date:  2021-02-09

4.  Localization of beta and high-frequency oscillations within the subthalamic nucleus region.

Authors:  B C M van Wijk; A Pogosyan; M I Hariz; H Akram; T Foltynie; P Limousin; A Horn; S Ewert; P Brown; V Litvak
Journal:  Neuroimage Clin       Date:  2017-07-24       Impact factor: 4.881

5.  Accuracy of Intraoperative Computed Tomography in Deep Brain Stimulation-A Prospective Noninferiority Study.

Authors:  Naomi I Kremer; D L Marinus Oterdoom; Peter Jan van Laar; Dan Piña-Fuentes; Teus van Laar; Gea Drost; Arjen L J van Hulzen; J Marc C van Dijk
Journal:  Neuromodulation       Date:  2019-01-10

6.  White matter tracing combined with electric field simulation - A patient-specific approach for deep brain stimulation.

Authors:  Teresa Nordin; Peter Zsigmond; Sonia Pujol; Carl-Fredrik Westin; Karin Wårdell
Journal:  Neuroimage Clin       Date:  2019-10-25       Impact factor: 4.881

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.